Sign in
4/A

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-028095

Chief Executive Officer gave up 3,695.93 shares (to pay taxes)

  • Chief Executive Officer acquired 3,462 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-16 Exercise or conversion : show line 1 in the form +3,462 $57.76 $199,965 444,448 D
2023-11-16 Shares withheld for taxes : show line 2 in the form −1,343 $148.90 $199,973 443,105 D
2023-11-20 Shares withheld for taxes : show line 3 in the form −2,352.93 $148.94 $350,445 440,752 D

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-16 Exercise or conversion : show line 4 in the form ResMed Common Stock Options −3,462 0 D
2023-11-16 Grant or award : show line 5 in the form ResMed Common Stock Options +55,468 $148.90 $8,259,185 55,468 D
Loading xslF345X05/form4a.xml…